Palisade Bio, Inc. (NASDAQ:PALI – Get Free Report) was the target of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totalling 35,200 shares, a decrease of 80.3% from the April 30th total of 178,500 shares. Currently, 3.8% of the shares of the company are […]
Palisade's ulcerative colitis drug prevents symptoms in mice fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
PALI Stock Earnings: Palisade Bio Beats EPS for Q1 2024 biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.
Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.